Jun Zhu, PhD is a professor in Department of Genetics and Genomic Sciences and a member of the Icahn Institute for Data Science and Genomic Technology. Dr. Zhu was trained in both computer science and biomedical science. His research focuses on methodologies for integrating diverse data (e.g. genetic, genomic, transcriptomic, proteomic data and etc.) into probabilistic graphic networks for elucidating complex human diseases, as well as method development for analyzing and comparing disease-related networks. Before joining Mount Sinai, he worked in both industry (Amgen, Inc, and Rosetta/Merck & CO, Inc) and academia (Sage Bionetworks, and Fred Hutchinson Cancer Research Center).
Genetics, Genomics, Mathematical Modeling of Biomedical Systems, Mathematical and Computational Biology
Multi-Disciplinary Training Areas
Genetics and Data Science [GDS], Pharmacology and Therapeutics Discovery [PTD]
BE, Tsinghua University
MS, State University of New York at Albany
Ph D, State University of New York at Albany
For more details about Dr. Zhu’s research, visit Dr. Zhu’s Integrative Network Biology group .
The explosion of large-scale, high-throughput technologies in the biological sciences demands a comprehensive view of biological systems. Dr. Zhu’s research focuses on analyzing large-scale high-throughput data:
1. Method development in integrating diverse high-throughput data into probabilistic causal network models.
2. Method development in comparing multiple networks.
3. Method development in analyzing biological networks.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Zhu during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.